Table 2 Professional practice regarding prevention and screening
Total number of participants: N = 300 | |
|---|---|
Yes | |
n (%) | |
Prevention | |
Systematic prevention | 190/300 (63.3) |
1st consultation (pre/peri conception/1st trimester) | 169/190 (88.9) |
Pre conceptional | 88/190 (46.3) |
1st trimester | 150/190 (78.9) |
2nd trimester | 36/190 (18.9) |
3rd trimester | 30/190 (15.8) |
Post partum | 21/190 (11.1) |
Reasons for not providing information | 110/300 (36.7) |
Lack of time | 13/110 (11.8) |
Lack of knowledge on the subject | 26/110 (23.6) |
Rare virus | 6/110 (5.5) |
Forgotten | 27/110 (24.5) |
Not recommended | 12/110 (10.9) |
Screening | |
Systematic screening | 137/300 (45.7) |
1st consultation (pre/peri conception/1st trimester) | 132/137 (96.3) |
Pre conceptional | 42/137 (30.7) |
1st trimester | 123/137 (89.8) |
2nd trimester | 17/137 (12.4) |
3rd trimester | 7/137 (5.1) |
Post partum | 1/137 (0.7) |
Target group for screening | 112/300 (37.3) |
After potential contamination | 40/112 (35.7) |
At the patient's request | 39/112 (34.8) |
If ultrasound sign | 38/112 (33.9) |
Seronegative patient | 12/112 (10.7) |
Patient in contact with young children | 56/112 (50.0) |
No screening | 51/300 (17.0) |